SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler
Since December 2019, the Coronavirus Disease 2019 (COVID-19) pandemic has become a non-neglectable context for the whole healthcare system. Under the background of COVID-19, the detection and diagnosis of malaria cases are under challenge. Here, we reported a COVID-19 and malaria co-infection travel...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.871374/full |
| _version_ | 1828427974614974464 |
|---|---|
| author | Qian Huang Wen-Jie Xu Xiao-Xiao Wang Xuan Zhang Ke-Nu Pan Jia-Qi Zhang Hua-Liang Chen Wei Ruan Li-Nong Yao |
| author_facet | Qian Huang Wen-Jie Xu Xiao-Xiao Wang Xuan Zhang Ke-Nu Pan Jia-Qi Zhang Hua-Liang Chen Wei Ruan Li-Nong Yao |
| author_sort | Qian Huang |
| collection | DOAJ |
| description | Since December 2019, the Coronavirus Disease 2019 (COVID-19) pandemic has become a non-neglectable context for the whole healthcare system. Under the background of COVID-19, the detection and diagnosis of malaria cases are under challenge. Here, we reported a COVID-19 and malaria co-infection traveler who has a long living history in Cameroon. The case was administered with dihydroartemisinin and piperaquine tablets for malaria, Lopinavir and Ritonavir tablets, Arbidol, recombinant human interferon α-2b and Compound Maxing Yifei mixture for COVID-19, and Zolpidem Tartrate tablets, Diazepam, Paroxetine Hydrochloride tablets, Thymosin α1, and Lianhua Qinwen Jiaonang during the second hospitalization of the patient since the patient has a certain level of anxiety and insomnia with no evidence of inflammatory reactions. After being tested negative two times for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 48 h, the patient met China's COVID-19 discharge standards and was discharged with stable vital signs and mental state. Since most countries in the sub-Saharan region have a fragile health system, co-infection for both Plasmodium and SARS-CoV-2 may not be uncommon, and raise a challenge in diagnosis, treatment, and prevention for both diseases. We add to the literature on co-infection of P. falciparum malaria and COVID-19 and offer operational advice on diagnosis, prevention, and treatment for the co-infection. |
| first_indexed | 2024-12-10T17:10:58Z |
| format | Article |
| id | doaj.art-a28a16a8a3a44fff94c29771d12fa7f9 |
| institution | Directory Open Access Journal |
| issn | 2296-2565 |
| language | English |
| last_indexed | 2024-12-10T17:10:58Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj.art-a28a16a8a3a44fff94c29771d12fa7f92022-12-22T01:40:19ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-08-011010.3389/fpubh.2022.871374871374SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning TravelerQian Huang0Wen-Jie Xu1Xiao-Xiao Wang2Xuan Zhang3Ke-Nu Pan4Jia-Qi Zhang5Hua-Liang Chen6Wei Ruan7Li-Nong Yao8Department of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou, ChinaDepartment of Infectious Diseases, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, ChinaDepartment of Infectious Diseases, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, ChinaDepartment of Infectious Diseases, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, ChinaMedical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, ChinaDepartment of Infectious Diseases, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, ChinaDepartment of Infectious Diseases, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, ChinaDepartment of Infectious Diseases, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, ChinaDepartment of Infectious Diseases, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, ChinaSince December 2019, the Coronavirus Disease 2019 (COVID-19) pandemic has become a non-neglectable context for the whole healthcare system. Under the background of COVID-19, the detection and diagnosis of malaria cases are under challenge. Here, we reported a COVID-19 and malaria co-infection traveler who has a long living history in Cameroon. The case was administered with dihydroartemisinin and piperaquine tablets for malaria, Lopinavir and Ritonavir tablets, Arbidol, recombinant human interferon α-2b and Compound Maxing Yifei mixture for COVID-19, and Zolpidem Tartrate tablets, Diazepam, Paroxetine Hydrochloride tablets, Thymosin α1, and Lianhua Qinwen Jiaonang during the second hospitalization of the patient since the patient has a certain level of anxiety and insomnia with no evidence of inflammatory reactions. After being tested negative two times for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 48 h, the patient met China's COVID-19 discharge standards and was discharged with stable vital signs and mental state. Since most countries in the sub-Saharan region have a fragile health system, co-infection for both Plasmodium and SARS-CoV-2 may not be uncommon, and raise a challenge in diagnosis, treatment, and prevention for both diseases. We add to the literature on co-infection of P. falciparum malaria and COVID-19 and offer operational advice on diagnosis, prevention, and treatment for the co-infection.https://www.frontiersin.org/articles/10.3389/fpubh.2022.871374/fullCOVID-19Sub-Saharan Africaco-infectionPlasmodium falciparummalariaSARS-CoV-2 |
| spellingShingle | Qian Huang Wen-Jie Xu Xiao-Xiao Wang Xuan Zhang Ke-Nu Pan Jia-Qi Zhang Hua-Liang Chen Wei Ruan Li-Nong Yao SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler Frontiers in Public Health COVID-19 Sub-Saharan Africa co-infection Plasmodium falciparum malaria SARS-CoV-2 |
| title | SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler |
| title_full | SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler |
| title_fullStr | SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler |
| title_full_unstemmed | SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler |
| title_short | SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler |
| title_sort | sars cov 2 and plasmodium falciparum co infection in a returning traveler |
| topic | COVID-19 Sub-Saharan Africa co-infection Plasmodium falciparum malaria SARS-CoV-2 |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2022.871374/full |
| work_keys_str_mv | AT qianhuang sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler AT wenjiexu sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler AT xiaoxiaowang sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler AT xuanzhang sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler AT kenupan sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler AT jiaqizhang sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler AT hualiangchen sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler AT weiruan sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler AT linongyao sarscov2andplasmodiumfalciparumcoinfectioninareturningtraveler |